SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001839882-23-033684
Filing Date
2023-12-14
Accepted
2023-12-14 06:04:46
Documents
14
Period of Report
2023-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT rain_8k-121323.htm   iXBRL 8-K 67473
2 AGREEMENT AND PLAN OF MERGER ex2-1.htm EX-2.1 819165
3 PRESS RELEASE OF THE COMPANY ex99-1.htm EX-99.1 23684
  Complete submission text file 0001839882-23-033684.txt   1261566

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rain-20231213.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rain-20231213_lab.xml EX-101.LAB 34916
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rain-20231213_pre.xml EX-101.PRE 22797
8 EXTRACTED XBRL INSTANCE DOCUMENT rain_8k-121323_htm.xml XML 3555
Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Oncology Inc. (Filer) CIK: 0001724979 (see all company filings)

IRS No.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40356 | Film No.: 231485495
SIC: 2834 Pharmaceutical Preparations